Abstract | OBJECTIVES: We sought to study factors predictive of achieving menstrual suppression with norethindrone vs. norethindrone acetate in adolescents, as optimal dosing is unknown. Secondary outcomes included analyzing prescriber practices and patient satisfaction. METHODS: We performed a retrospective chart review of adolescents ages <18 years presenting to an academic medical center from 2010 to 2022. Data collected included demographics, menstrual history, and norethindrone and norethindrone acetate use. Follow-up was measured at one, three, and 12 months. Main outcome measures were starting norethindrone 0.35 mg, continuing norethindrone 0.35 mg, achieving menstrual suppression, and patient satisfaction. Analysis included Chi-square and multivariate logistic regression. RESULTS: CONCLUSIONS:
|
Authors | Theresa L Rager, Sarah D Compton, Olivia K Winfrey, Monica W Rosen |
Journal | Journal of pediatric endocrinology & metabolism : JPEM
(J Pediatr Endocrinol Metab)
Vol. 36
Issue 8
Pg. 732-739
(Aug 28 2023)
ISSN: 2191-0251 [Electronic] Germany |
PMID | 37279406
(Publication Type: Journal Article)
|
Copyright | © 2023 the author(s), published by De Gruyter, Berlin/Boston. |
Chemical References |
- Norethindrone
- Norethindrone Acetate
|
Topics |
- Female
- Adolescent
- Humans
- Norethindrone
(adverse effects)
- Menorrhagia
(chemically induced)
- Norethindrone Acetate
- Retrospective Studies
- Obesity
|